FINDINGS OF SCIENTIFIC MISCONDUCT Release Date: June 18, 1999 P.T. Department of Health and Human Services Notice is hereby given that the Office of Research Integrity (ORI) has made a final finding of scientific misconduct in the following case: Robert P. Liburdy, Ph.D., Lawrence Berkeley National Laboratory: Based on an investigation report by the Lawrence Berkeley National Laboratory (LBNL) dated July 7, 1995, and an analysis of the data and information from Dr. Liburdy obtained by ORI during its oversight review, ORI found that Dr. Liburdy, former staff biochemist at LBNL, engaged in scientific misconduct in biomedical research by intentionally falsifying and fabricating data and claims about the purported cellular effects of electric and magnetic fields (EMF) that were reported in two scientific papers: (1) Liburdy, R.P. \"Biological interactions of cellular systems with time-varying magnetic fields. Annals of the New York Academy of Sciences 649:74-95, 1992 (\"ANYAS paper\"); and (2) Liburdy, R.P. \"Calcium signaling in lymphocytes and ELF fields.\" FEBS Letters 301:53-59, 1992 (the \"FEBS Letters paper\"). The ANYAS and FEBS Letters papers were supported by a National Cancer Institute (NCI), National Institutes of Health (NIH), grant. The ANYAS and FEBS Letters papers reported data indicating that EMF exert a biological effect by altering the entry of calcium across a cell\'s surface membrane. EMF, which are ubiquitous forms of radiation that arise from diverse sources such as power lines, home wiring, and household appliances, have been of public concern for potential health effects. Dr. Liburdy\'s claims were potentially very important when published in 1992 because they purported to link EMF and calcium signaling, a fundamental cell process governing many important cellular functions. Dr. Liburdy has entered into Voluntary Exclusion Agreement with ORI. As part of this Agreement, Dr. Liburdy neither admits nor denies ORI\'s finding of scientific misconduct. The settlement is not an admission of liability on the part of the respondent. As part of the Voluntary Exclusion Agreement, Dr. Liburdy has voluntarily agreed: (1) to exclude himself from any contracting or subcontracting with any agency of the United States Government and from eligibility for, or involvement in, nonprocurement transactions (e.g., grants and cooperative agreements) of the United States Government as defined in 45 C.F. R. Part 76 (Debarment Regulations) for the three (3) year period beginning May 28, 1999; (2) to exclude himself from serving in any advisory capacity to the Public Health Service (PHS), including but not limited to service on any PHS advisory committee, board, and/or peer review committee, or as a consultant for the three (3) year period beginning May 28, 1999; and (3) to submit letters to the journals ANYAS and FEBS Letters, requesting retraction of Figure 12 of the ANYAS paper and of Figures 6 and 7 of the FEBS Letters paper within 30 days of the date of the agreement. INQUIRIES For further information contact: Acting Director Division of Research Investigations Office of Research Integrity 5515 Security Lane, Suite 700 Rockville, MD 20852 Telephone: (301) 443-5330
